International Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate ferric carboxymaltose therapy in patients with cardiac amyloidosis combined with iron deficiency (Reward)

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132906) titled 'A randomized, double-blind, placebo-controlled study to evaluate ferric carboxymaltose therapy in patients with cardiac amyloidosis combined with iron deficiency (Reward)' on Sept. 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College

Condition: Cardiac amyloidosis complicated by iron deficiency

Intervention: Control group:A placebo (100 ml of 0.9% sodium chloride injection) was administered via intravenous infusion. Intervention group:Ferric carboxymaltose 1000 mg is dissolved in 100 mL of 0.9% sodi...